ITeos Therapeutics Inc (ITOS)
17.44
+5.25
(+43.07%)
USD |
NASDAQ |
May 10, 16:00
17.66
+0.22
(+1.26%)
After-Hours: 18:41
ITeos Therapeutics Price to Book Value: 1.087 for May 10, 2024
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
May 09, 2024 | 0.7596 |
May 08, 2024 | 0.7602 |
May 07, 2024 | 0.7671 |
May 06, 2024 | 0.7733 |
May 03, 2024 | 0.7265 |
May 02, 2024 | 0.716 |
May 01, 2024 | 0.734 |
April 30, 2024 | 0.6692 |
April 29, 2024 | 0.6717 |
April 26, 2024 | 0.673 |
April 25, 2024 | 0.6605 |
April 24, 2024 | 0.6586 |
April 23, 2024 | 0.6848 |
April 22, 2024 | 0.6723 |
April 19, 2024 | 0.658 |
April 18, 2024 | 0.6437 |
April 17, 2024 | 0.6655 |
April 16, 2024 | 0.6917 |
April 15, 2024 | 0.7328 |
April 12, 2024 | 0.7303 |
April 11, 2024 | 0.7664 |
April 10, 2024 | 0.7627 |
April 09, 2024 | 0.7882 |
April 08, 2024 | 0.7614 |
April 05, 2024 | 0.7702 |
Date | Value |
---|---|
April 04, 2024 | 0.7752 |
April 03, 2024 | 0.8175 |
April 02, 2024 | 0.7901 |
April 01, 2024 | 0.8312 |
March 28, 2024 | 0.8499 |
March 27, 2024 | 0.8206 |
March 26, 2024 | 0.7695 |
March 25, 2024 | 0.7072 |
March 22, 2024 | 0.6973 |
March 21, 2024 | 0.7103 |
March 20, 2024 | 0.6898 |
March 19, 2024 | 0.673 |
March 18, 2024 | 0.6393 |
March 15, 2024 | 0.6736 |
March 14, 2024 | 0.6686 |
March 13, 2024 | 0.7085 |
March 12, 2024 | 0.7197 |
March 11, 2024 | 0.7434 |
March 08, 2024 | 0.772 |
March 07, 2024 | 0.7216 |
March 06, 2024 | 0.7403 |
March 05, 2024 | 0.6867 |
March 04, 2024 | 0.6917 |
March 01, 2024 | 0.7022 |
February 29, 2024 | 0.6673 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.5129
Minimum
Oct 12 2023
4.793
Maximum
Mar 02 2021
1.788
Average
1.206
Median
Nov 11 2022
Price to Book Value Benchmarks
IGM Biosciences Inc | 2.705 |
Forian Inc | 3.128 |
CEL-SCI Corp | 6.059 |
AIM ImmunoTech Inc | 2.108 |
IGC Pharma Inc | 3.593 |
Price to Book Value Related Metrics
PS Ratio | 4.884 |
Price | 17.44 |
Earnings Yield | -18.06% |
Market Cap | 625.10M |
Normalized PE Ratio | 60.14 |